Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI
The proposed asset sale combines cash and NANO Nuclear shares, while regulatory, site and environmental conditions remain outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Radnostix (INIS) and NANO Nuclear jointly submitted a letter of intent seeking NRC consent to transfer Material License SUB-1011.
The license would pass to NANO Nuclear subsidiary HALEU Energy Fuel under the September 28, 2026 agreement to acquire Radnostix's depleted uranium hexafluoride deconversion and fluorine extraction assets. Consideration comprises $9.5 million in cash, including a previously funded $0.5 million deposit, and $4.0 million in NANO common stock valued using the contractual volume-weighted average price formula.
Lea County authorized a property letter of intent covering approximately 640 acres, but the property transfer is not complete. The parties target closing in approximately 90 to 120 days, subject to NRC consent, final county site arrangements, environmental assessments satisfactory to HALEU Energy Fuel and other required approvals and consents.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major point. Forward-looking: it has not happened yet and may not happen.Asset-sale consideration includes $9.5 million cash, including NANO Nuclear's previously funded $0.5 million deposit. 40% of market cap
- Minor point. Forward-looking: it has not happened yet and may not happen.Additional consideration comprises $4.0 million in NANO common stock, valued using the contractual volume-weighted average price formula.
- Minor point. Forward-looking: it has not happened yet and may not happen.Radnostix expects the asset sale to allow greater focus on radioisotope technologies.
Negative
- Moderate pointNRC consent remains a closing condition; the parties expect to submit a formal consent application.
- Moderate pointFinal site arrangements remain pending; Lea County's property letter of intent does not complete the transfer.
- Minor pointEnvironmental assessments satisfactory to HALEU Energy Fuel and other required approvals and consents remain closing conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The joint Letter of Intent requests NRC consent under 10 CFR 40.46 for the transfer of control of License SUB-1011 from Radnostix and its subsidiary International Isotopes Fluorine Products, Inc. to NANO Nuclear's wholly owned subsidiary, HALEU Energy Fuel Inc. The parties expect to follow the Letter of Intent with a formal consent application. NRC consent is a key closing condition of the Asset Purchase Agreement entered into on September 28, 2026.
This NRC step follows the Lea County Board of County Commissioners' unanimous passage of Resolution No. 26-SEP-229R. That resolution authorized a Letter of Intent between Lea County and NANO Nuclear for the potential transfer of approximately 640 acres in Section 27, Township 18 South, Range 36 East, N.M.P.M. (the former International Isotopes DUF6 deconversion project site).
The joint NRC Letter of Intent and the County property LOI are linked milestones supporting the transaction under which HALEU Energy Fuel Inc. would acquire the DUF6 deconversion and fluorine extraction assets, including License SUB-1011. The assets are expected to accelerate NANO Nuclear's domestic nuclear fuel-cycle capabilities by several years while allowing Radnostix to focus on radioisotope technologies.
The Hobbs Site comprises approximately 640 acres and is associated with the Company's previously planned depleted uranium hexafluoride ("DUF6") deconversion and fluorine extraction facility and
Management Comment
"Our joint submission to the NRC marks another important step toward completing this strategic transaction. With the process advancing as anticipated, we remain on track toward closing and positioning NANO Nuclear to further strengthen its role within the
Shahe Bagerdjian, Chief Executive Officer of Radnostix, added: "The joint submission seeking NRC consent for the transfer of License SUB-1011, together with the County's Letter of Intent approval, provides clear momentum for getting to closing and remain confident we will get there within our agreed timelines."
Transaction and Site Transfer Next Steps
The parties continue to target a closing of the Asset Purchase Agreement in approximately 90 to 120 days. Closing remains subject to NRC consent to transfer Material License SUB-1011 to HEF, final site arrangements with Lea County, completion of environmental assessments satisfactory to HEF, other required approvals and consents, and other customary closing conditions. Under the previously announced asset purchase agreement, the agreed consideration comprises
About Radnostix (formerly International Isotopes Inc.): Radnostix, Inc. (formerly International Isotopes Inc.) (INIS), established in 1995, with its headquarters in Idaho Falls, ID, USA, manufactures a wide range of radioisotope technology products. Radnostix manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer, the contract manufacturing of various drug products as well as radioisotope API supply for 3rd party theranostics clients. Radnostix also manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and SPECT/PET imaging systems as well as industrial calibration standards under its RadQual brand. For more information, visit www.radnostix.com.
Radnostix, Inc. (formerly International Isotopes Inc.) Safe Harbor Statement:
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including but not limited to, statements regarding the Company's current expected financial impact from the Asset Purchase Agreement described herein, the estimated value of the DUF6 Plant and related assets, statements with respect to the Company's future growth expectations. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance, or achievements of Radnostix, Inc. to be materially different from any future results, performance or achievements of the Company expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company's filings with the Securities and Exchange Commission at www.sec.gov, including its Annual Report on Form 10-K for the year ended December 31, 2025. Investors, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and Radnostix, Inc. and the Company undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
Radnostix Contact:
ir@intisoid.com
radnostix.com
View original content:SOURCE International Isotopes Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What would Radnostix receive from the NANO Nuclear asset sale?
The agreed consideration is $9.5 million in cash and NANO common stock valued at $4.0 million, subject to the agreement's terms. The cash includes the $0.5 million deposit previously funded by NANO Nuclear. The stock valuation uses the contractual volume-weighted average price formula.
When is the Radnostix asset sale to NANO Nuclear expected to close?
The parties continue to target closing in approximately 90 to 120 days. Completion depends on NRC consent to transfer License SUB-1011, final site arrangements with Lea County, environmental assessments satisfactory to HALEU Energy Fuel, and other required approvals, consents and customary closing conditions.
What follows Radnostix and NANO Nuclear's NRC letter of intent?
The parties expect to follow the letter of intent with a formal consent application. They are seeking NRC consent under 10 CFR 40.46 to transfer control of Material License SUB-1011 from Radnostix and International Isotopes Fluorine Products to HALEU Energy Fuel.